MOTIVATION: In the post genome-wide association study (GWAS) era, omics techniques have characterized information beyond genomic variants to include cell and tissue type-specific gene transcription, transcription factor binding sites, expression quantitative trait loci (eQTL), and many other biological layers. Analysis of omics data and its integration has in turn improved the functional interpretation of disease-associated genetic variants. Over 170,000 transcriptomic and epigenomic datasets corresponding to studies of various cell and tissue types under specific disease, treatment, and exposure conditions are available in the Gene Expression Omnibus resource. Although these datasets are valuable to guide the design of experimental validation studies to understand the function of disease-associated genetic loci, in their raw form, they are not helpful to experimental researchers who lack adequate computational resources or experience analyzing omics data. We sought to create an integrated re-source of tissue-specific results from omics studies that is guided by disease-specific knowledge to facilitate the design of experiments that can provide biologically meaningful insights into genetic as-sociations. RESULTS: We designed the Reducing Associations by Linking Genes And omics Results (REALGAR) web app to provide multi-layered omics information based on results from GWAS, transcriptomic, epigenomic, and eQTL studies for gene-centric analysis and visualization. With a focus on asthma datasets, the integrated omics results it contains facilitate the formulation of hypotheses related to airways disease-associated genes and can be addressed with experimental validation studies. AVAILABILITY: The REALGAR web app is available at: http://realgar.org/. The source code is available at: https://github.com/HimesGroup/realgar. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
MOTIVATION: In the post genome-wide association study (GWAS) era, omics techniques have characterized information beyond genomic variants to include cell and tissue type-specific gene transcription, transcription factor binding sites, expression quantitative trait loci (eQTL), and many other biological layers. Analysis of omics data and its integration has in turn improved the functional interpretation of disease-associated genetic variants. Over 170,000 transcriptomic and epigenomic datasets corresponding to studies of various cell and tissue types under specific disease, treatment, and exposure conditions are available in the Gene Expression Omnibus resource. Although these datasets are valuable to guide the design of experimental validation studies to understand the function of disease-associated genetic loci, in their raw form, they are not helpful to experimental researchers who lack adequate computational resources or experience analyzing omics data. We sought to create an integrated re-source of tissue-specific results from omics studies that is guided by disease-specific knowledge to facilitate the design of experiments that can provide biologically meaningful insights into genetic as-sociations. RESULTS: We designed the Reducing Associations by Linking Genes And omics Results (REALGAR) web app to provide multi-layered omics information based on results from GWAS, transcriptomic, epigenomic, and eQTL studies for gene-centric analysis and visualization. With a focus on asthma datasets, the integrated omics results it contains facilitate the formulation of hypotheses related to airways disease-associated genes and can be addressed with experimental validation studies. AVAILABILITY: The REALGAR web app is available at: http://realgar.org/. The source code is available at: https://github.com/HimesGroup/realgar. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Authors: Milton Pividori; Nathan Schoettler; Dan L Nicolae; Carole Ober; Hae Kyung Im Journal: Lancet Respir Med Date: 2019-04-27 Impact factor: 30.700
Authors: Mengyuan Kan; Avantika R Diwadkar; Haoyue Shuai; Jaehyun Joo; Alberta L Wang; Mei-Sing Ong; Joanne E Sordillo; Carlos Iribarren; Meng X Lu; Natalia Hernandez-Pacheco; Javier Perez-Garcia; Mario Gorenjak; Uroš Potočnik; Esteban G Burchard; Maria Pino-Yanes; Ann Chen Wu; Blanca E Himes Journal: J Allergy Clin Immunol Date: 2021-12-28 Impact factor: 14.290
Authors: Anja Ragvin; Enrico Moro; David Fredman; Pavla Navratilova; Øyvind Drivenes; Pär G Engström; M Eva Alonso; Elisa de la Calle Mustienes; José Luis Gómez Skarmeta; Maria J Tavares; Fernando Casares; Miguel Manzanares; Veronica van Heyningen; Anders Molven; Pål R Njølstad; Francesco Argenton; Boris Lenhard; Thomas S Becker Journal: Proc Natl Acad Sci U S A Date: 2009-12-22 Impact factor: 11.205
Authors: Joseph Nasser; Drew T Bergman; Charles P Fulco; Philine Guckelberger; Benjamin R Doughty; Tejal A Patwardhan; Thouis R Jones; Tung H Nguyen; Jacob C Ulirsch; Fritz Lekschas; Kristy Mualim; Heini M Natri; Elle M Weeks; Glen Munson; Michael Kane; Helen Y Kang; Ang Cui; John P Ray; Thomas M Eisenhaure; Ryan L Collins; Kushal Dey; Hanspeter Pfister; Alkes L Price; Charles B Epstein; Anshul Kundaje; Ramnik J Xavier; Mark J Daly; Hailiang Huang; Hilary K Finucane; Nir Hacohen; Eric S Lander; Jesse M Engreitz Journal: Nature Date: 2021-04-07 Impact factor: 69.504
Authors: Haijun Zhang; Mahboubeh R Rostami; Philip L Leopold; Jason G Mezey; Sarah L O'Beirne; Yael Strulovici-Barel; Ronald G Crystal Journal: Am J Respir Crit Care Med Date: 2020-07-15 Impact factor: 21.405
Authors: Marie E Killerby; Ruth Link-Gelles; Sarah C Haight; Caroline A Schrodt; Lucinda England; Danica J Gomes; Mays Shamout; Kristen Pettrone; Kevin O'Laughlin; Anne Kimball; Erin F Blau; Eleanor Burnett; Chandresh N Ladva; Christine M Szablewski; Melissa Tobin-D'Angelo; Nadine Oosmanally; Cherie Drenzek; David J Murphy; James M Blum; Julie Hollberg; Benjamin Lefkove; Frank W Brown; Tom Shimabukuro; Claire M Midgley; Jacqueline E Tate Journal: MMWR Morb Mortal Wkly Rep Date: 2020-06-26 Impact factor: 17.586